IL-33 is the most recent addition to the IL-1 cytokine family, identified in 2005 as the ligand of T1/ST2 and inducer of type-2 immune responses. IL-33 has been implicated in a wide range of disease settings, in anti-inflammatory responses and homeostasis, and thus signalling must be strictly regulated. Altered gene expression, post-translational modification, decoy receptor, and receptor signalling are all modulatory mechanisms used to control the IL-33 pathway. Understanding both the genetic and post-translational factors influencing IL-33 activity will be critical for provision of safe effective treatment of type-2 disorders
IL-33 is a novel cytokine of the IL-1 family and mediates its biological effect via the receptor ST2...
Artículo de publicación ISIIL-33, an IL-1 family member, is expressed by many cell types and can reg...
International audienceIL-33 (or IL-1F11) was recently identified as a ligand for the previously orph...
IL-33 is the most recent addition to the IL-1 cytokine family, identified in 2005 as the ligand of T...
Interleukin-33 (IL-33) is a new cytokine of interleukin-1 family, whose specific receptor is ST2. IL...
Interleukin-33 (IL-33) — a member of the IL-1 family — was originally described as an inducer of typ...
Interleukin (IL)-33 is a recently identified pleiotropic cytokine, which can orchestrate complex inn...
Interleukin 33 (IL33) is a recently described member of the IL1 superfamily of cytokines. Originally...
Interleukin (IL)-33 is a recently identified pleiotropic cytokine, which can orchestrate complex inn...
Interleukin 33 (IL33) is a recently described member of the IL1 superfamily of cytokines. Originally...
Abstract Interleukin-33 (IL-33) is a 30KDa protein, which belongs to the Interleukin-1 cytokine fami...
Interleukin-33 (IL-33), a newly described member of the IL-1 family, is expressed by many cell types...
ABSTRACTInterleukin-33 (IL-33) is a member of the IL-1 cytokine family, which includes IL-1 and IL-1...
IL-33 is a known member of the IL-1 cytokine superfamily classically named “atypical” due to its div...
Interleukin-33 (IL-33) is a nuclear-associated cytokine of the IL-1 family originally described as a...
IL-33 is a novel cytokine of the IL-1 family and mediates its biological effect via the receptor ST2...
Artículo de publicación ISIIL-33, an IL-1 family member, is expressed by many cell types and can reg...
International audienceIL-33 (or IL-1F11) was recently identified as a ligand for the previously orph...
IL-33 is the most recent addition to the IL-1 cytokine family, identified in 2005 as the ligand of T...
Interleukin-33 (IL-33) is a new cytokine of interleukin-1 family, whose specific receptor is ST2. IL...
Interleukin-33 (IL-33) — a member of the IL-1 family — was originally described as an inducer of typ...
Interleukin (IL)-33 is a recently identified pleiotropic cytokine, which can orchestrate complex inn...
Interleukin 33 (IL33) is a recently described member of the IL1 superfamily of cytokines. Originally...
Interleukin (IL)-33 is a recently identified pleiotropic cytokine, which can orchestrate complex inn...
Interleukin 33 (IL33) is a recently described member of the IL1 superfamily of cytokines. Originally...
Abstract Interleukin-33 (IL-33) is a 30KDa protein, which belongs to the Interleukin-1 cytokine fami...
Interleukin-33 (IL-33), a newly described member of the IL-1 family, is expressed by many cell types...
ABSTRACTInterleukin-33 (IL-33) is a member of the IL-1 cytokine family, which includes IL-1 and IL-1...
IL-33 is a known member of the IL-1 cytokine superfamily classically named “atypical” due to its div...
Interleukin-33 (IL-33) is a nuclear-associated cytokine of the IL-1 family originally described as a...
IL-33 is a novel cytokine of the IL-1 family and mediates its biological effect via the receptor ST2...
Artículo de publicación ISIIL-33, an IL-1 family member, is expressed by many cell types and can reg...
International audienceIL-33 (or IL-1F11) was recently identified as a ligand for the previously orph...